A novel electrochemiluminescent sensor based on AgMOF@N-CD composites for sensitive detection of trilobatin-Reference-Cited by-同舟云学术

A novel electrochemiluminescent sensor based on AgMOF@N-CD composites for sensitive detection of trilobatin

Published:2024 Issue: Volume: Page:
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Yao Longmei¹,Mei Xue¹,Zhi Jiajia¹,Wang Wenchang¹²,Li Qingyi³,Jiang Ding¹,Chen Xiaohui⁴^ORCID,Chen Zhidong¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of Advanced Catalytic Materials and Technology, School of Petrochemical Engineering, Changzhou University, Changzhou, 213164, China

2. Analysis and Testing Center, NERC Biomass of Changzhou University, Jiangsu, 213032, China

3. Changzhou High-Tech Industry Development Zone Sanwei Industrial Technology Research Instit. Co., Ltd, Changzhou, 213164, China

4. School of Chemistry and Material Engineering, Changzhou Institute of Technology, Changzhou 213032, China

Abstract

In this study, a novel electrochemiluminescent (ECL) sensor for highly sensitive detection of trilobatin (Tri) was developed based on silver metal–organic frameworks (AgMOFs) and nitrogen-doped carbon quantum dots (N-CDs).

Funder

National Natural Science Foundation of China

Changzhou Science and Technology Bureau

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/AN/D4AN01102C

Reference40 articles.

1. Trilobatin ameliorates HFD/STZ-induced glycolipid metabolism disorders through AMPK-mediated pathways

2. Effects of natural dihydrochalcones in sweet tea (Lithocarpus polystachyus) on diabetes: a systematical review and meta-analysis of animal studies

3. Trilobatin, a Natural Food Additive, Exerts Anti-Type 2 Diabetes Effect Mediated by Nrf2/ARE and IRS-1/GLUT2 Signaling Pathways

4. Trilobatin Ameliorates Inflammatory Response by Regulating the miR375-Mediated Fatty Acid Binding Protein 4 Expression in Adipocytes

5. Trilobatin Induces Apoptosis and Attenuates Stemness Phenotype of Acquired Gefitinib Resistant Lung Cancer Cells via Suppression of NF-κB Pathway